Search Results - "Meinke, S"

Targets for Ibrutinib Beyond B Cell Malignancies by Berglöf, A., Hamasy, A., Meinke, S., Palma, M., Krstic, A., Månsson, R., Kimby, E., Österborg, A., Smith, C. I. E.

“…Ibrutinib (Imbruvica™) is an irreversible, potent inhibitor of Bruton's tyrosine kinase (BTK). Over the last few years, ibrutinib has developed from a…”
Get full text

Antibody-dependent natural killer cell cytotoxicity: A potential mechanism of platelet lysis in immune thrombocytopenia by Schmied, L., Meinke, S., Brandt, Ludwig, Thanh, T. Luu, Karlstrom, C., Sandgren, P., Vidarsson, G., Önfelt, Björn, Hoglund, P.

Get full text

Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets by Refsum, E., Meinke, S., Gryfelt, G., Wikman, A., Höglund, P.

“…In fetal and neonatal alloimmune thrombocytopenia (FNAIT), maternal alloantibodies directed against paternally-derived platelet antigens are transported across…”
Get full text

Storage of red blood cells in a novel polyolefin blood container: a pilot in vitro study by Gulliksson, H., Meinke, S., Ravizza, A., Larsson, L., Höglund, P.

“…Background and Objectives The present general plasticizer di‐2‐ethylhexyl‐phthalate in polyvinylchloride (PVC) blood bags is only physically dispersed in PVC…”
Get full text

P1443: AUTOLOGOUS NK CELLS AS CONSOLIDATION AFTER FRONT‐LINE STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: A LONG‐TERM FOLLOW‐UP by Lund, J., Nahi, H., Meinke, S., Holmqvist, P.‐H., Ljunggren, H.‐G., Aschan, J., Alici, E.

Get full text

P1435: PRECLINICAL EVALUATION OF ZILOVERTAMAB‐BASED ANTI‐ROR1 CHIMERIC ANTIGEN RECEPTORS IN NK AND T CELLS by Meinke, S., Kadri, N., Bi, S., Bostancioglu, B., Markey, C., Breitmeyer, J. B., Hussain, A., Krishnan, R., Kaufmann, G. F., Alici, E.

Get full text

The Abl‐1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK Cell Education by Ganesan, S., Luu, T.T., Chambers, B. J., Meinke, S., Brodin, P., Vivier, E., Wetzel, D. M., Koleske, A.J., Kadri, N., Höglund, P.

“…Natural killer (NK) cell responsiveness in the mouse is determined in an education process guided by inhibitory Ly49 and NKG2A receptors binding to MHC class I…”
Get full text

Characterisation of maternal human leukocyte antigen class I antibodies in suspected foetal and neonatal alloimmune thrombocytopenia by Refsum, E., Mörtberg, A., Dahl, J., Meinke, S., Auvinen, M.‐K., Westgren, M., Reilly, M., Höglund, P., Wikman, A.

“…Summary Objectives To investigate the specificities and level of HLA class I antibodies in selected cases referred for suspected foetal and neonatal alloimmune…”
Get full text

POLYGONALIZATION OF WHEEL TREADS CAUSED BY STATIC AND DYNAMIC IMBALANCES by MEINKE, P., MEINKE, S.

“…High speed wheelsets of railway systems differ from classical ones. These dynamics are determined by gyroscopic and inertia moments. A dynamical model with…”
Get full text

Platelet-Mediated Protection of Cancer Cells From Immune Surveillance - Possible Implications for Cancer Immunotherapy by Schmied, Laurent, Höglund, Petter, Meinke, Stephan

“…The growing insights in the complex interactions between metastatic cancer-cells and platelets have revealed that platelet tumor cell interactions in the blood…”
Get full text

Platelet transfusion improves clot formation and platelet function in severely thrombocytopenic haematology patients by Karlström, Cecilia, Gryfelt, Gunilla, Schmied, Laurent, Meinke, Stephan, Höglund, Petter

“…Summary Prophylactic platelet (PLT) transfusion is a common practice in severely thrombocytopenic patients that reduces mortality, but responses to platelet…”
Get full text

Complement as an Immune Barrier in Platelet Transfusion Refractoriness by Meinke, Stephan, Karlström, Cecilia, Höglund, Petter

“…Patients with hematological cancers often have low platelet counts because of progressing bone marrow failure or cytostatic therapy. A large fraction of those…”
Get full text

HSV1716 Infects Multiple Myeloma Cells and Leads to CD138 Downregulation by Susek, Katharina Helene, Flore, Viktoria Nina, Karvouni, Maria, Meinke, Stephan, Conner, Joe, Powers, Colin, Allen, Robert, Wagner, Arnika Kathleen, Alici, Evren

Get full text

Cryopreservation of buffy coat–derived platelet concentrates photochemically treated with amotosalen and UVA light by Meinke, Stephan, Wikman, Agneta, Gryfelt, Gunilla, Hultenby, Kjell, Uhlin, Michael, Höglund, Petter, Sandgren, Per

“…BACKGROUND Cryopreserved platelets (CPPs) are considered a promising approach for extended platelet storage, bridging inventory shortages of conventionally…”
Get full text

Perturbed NK-cell homeostasis associated with disease severity in chronic neutropenia by Sohlberg, Ebba, Pfefferle, Aline, Heggernes Ask, Eivind, Tschan-Plessl, Astrid, Jacobs, Benedikt, Netskar, Herman, Lorenz, Susanne, Kanaya, Minoru, Kosugi-Kanaya, Mizuha, Meinke, Stephan, Mörtberg, Anette, Höglund, Petter, Sundin, Mikael, Carlsson, Göran, Palmblad, Jan, Malmberg, Karl-Johan

“…Neutrophils have been thought to play a critical role in terminal differentiation of NK cells. Whether this effect is direct or a consequence of global immune…”
Get full text

The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes by Gavin, Caroline, Meinke, Stephan, Heldring, Nina, Heck, Kathleen Anne, Achour, Adnane, Iacobaeus, Ellen, Höglund, Petter, Le Blanc, Katarina, Kadri, Nadir

“…Mesenchymal stromal cell (MSC) therapy is a promising tool in the treatment of chronic inflammatory diseases. This has been ascribed to the capacity of MSC to…”
Get full text

Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies by Meinke, Stephan, Sandgren, Per, Mörtberg, Anette, Karlström, Cecilia, Kadri, Nadir, Wikman, Agneta, Höglund, Petter

“…BACKGROUND The presence of antibodies against HLA Class I can lead to platelet (PLT) transfusion refractoriness, that is, the repeated failure to achieve…”
Get full text

HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients by Mirlashari, Mohammad Reza, Vetlesen, Annette, Nissen‐Meyer, Lise Sofie H., Naper, Christian, Tjønnfjord, Geir Erland, Njerve, Ida Unhammer, Ezligini, Farshid, Landmark, Brynjar Fowels, Meinke, Stephan, Sandgren, Per, Höglund, Petter, Hetland, Geir

“…Background Patients can form antibodies to foreign human leukocyte antigen (HLA) Class I antigens after exposure to allogeneic cells. These anti‐HLA class I…”
Get full text

IL‐15 and CD155 expression regulate LAT expression in murine DNAM1+ NK cells, enhancing their effectors functions by Luu, Thuy T., Wagner, Arnika K., Schmied, Laurent, Meinke, Stephan, Freund, Jacquelyn E., Kambayashi, Taku, Ravens, Inga, Achour, Adnane, Bernhardt, Gunter, Chambers, Benedict J., Höglund, Petter, Kadri, Nadir

“…NK cells are innate immune cells characterized by their ability to spontaneously lyse tumor and virally infected cells. We have recently demonstrated that…”
Get full text

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion by Nahi, Hareth, Chrobook, Michael, Meinke, Stephan, Gran, Charlotte, Marquardt, Nicole, Afram, Gabriel, Sutlu, Tolga, Gilljam, Mari, Stellan, Birgitta, Wagner, Arnika Kathleen, Walther-Jallow, Lilian, Liwing, Johan, Klimkowska, Monika, Gahrton, Goesta, Ljungman, Per, Ljunggren, Hans-Gustaf, Alici, Evren

“…Introduction: Immunotherapies are gaining more and more importance in the treatment of multiple myeloma (MM). Antibodies directed against MM antigens like…”
Get full text